Therefore, determining hepcidin-25 concentration in the serum of IBD patients could be very useful for the assessment of anemia severity and treatment decisions, particularly during prolonged periods of active disease, when inflammation persists and severe anemia might develop. This evidence concerns the gene HAMP and inflammatory bowel disease.